Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PMV Pharmaceuticals Inc.

    NASDAQ: PMVP · Real-Time Price · USD
    1.10
    0.03 (2.80%)
    At close: Jun 17, 2025, 1:48 PM

    PMV Pharmaceuticals Statistics

    Share Statistics

    PMV Pharmaceuticals has 51.95M shares outstanding. The number of shares has increased by 0.95% in one year.

    Shares Outstanding

    n/a
    		 51.95M

    Shares Change (YoY)

    n/a
    		 0.95%

    Shares Change (QoQ)

    n/a
    		 0.36%

    Owned by Institutions (%)

    n/a
    		 75.54%

    Shares Floating

    n/a
    		 43.75M

    Failed to Deliver (FTD) Shares

    n/a
    		 11

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 854.29K, so 1.64% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 854.29K

    Short % of Shares Out

    n/a
    		 1.64%

    Short % of Float

    n/a
    		 1.95%

    Short Ratio (days to cover)

    n/a
    		 2.49

    Valuation Ratios

    The PE ratio is -1.33 and the forward PE ratio is -0.62. PMV Pharmaceuticals's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -1.33

    Forward PE

    n/a
    		 -0.62

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 0.44

    P/FCF Ratio

    n/a
    		 -1.5

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for PMV Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 12.22, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 12.22

    Quick Ratio

    n/a
    		 12.22

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,249,127.66

    Employee Count

    n/a
    		 47

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -16.1M

    Effective Tax Rate

    n/a
    		 21.52%

    Stock Price Statistics

    The stock price has increased by -35.15% in the last 52 weeks. The beta is 1.43, so PMV Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.43

    52-Week Price Change

    n/a
    		 -35.15%

    50-Day Moving Average

    n/a
    		 0.96

    200-Day Moving Average

    n/a
    		 1.34

    Relative Strength Index (RSI)

    n/a
    		 59.94

    Average Volume (20 Days)

    n/a
    		 218,822

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -85.45M

    Net Income

    n/a
    		 -58.71M

    EBITDA

    n/a
    		 -73.67M

    EBIT

    n/a
    		 -74.81M

    Earnings Per Share (EPS)

    n/a
    		 -1.14
    Full Income Statement

    Balance Sheet

    The company has 40.88M in cash and 1.19M in debt, giving a net cash position of 39.69M.

    Cash & Cash Equivalents

    n/a
    		 40.88M

    Total Debt

    n/a
    		 1.19M

    Net Cash

    n/a
    		 39.69M

    Retained Earnings

    n/a
    		 -368.71M

    Total Assets

    n/a
    		 170.61M

    Working Capital

    n/a
    		 153.74M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -51.28M and capital expenditures -655K, giving a free cash flow of -51.94M.

    Operating Cash Flow

    n/a
    		 -51.28M

    Capital Expenditures

    n/a
    		 -655K

    Free Cash Flow

    n/a
    		 -51.94M

    FCF Per Share

    n/a
    		 -1.01
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PMVP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PMVP is $5, which is 367.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 367.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.15

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist